Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)
dc.contributor.author | Surmeli, Z | |
dc.contributor.author | Bozkurt, E | |
dc.contributor.author | Ozer, O | |
dc.contributor.author | Atmaca, H | |
dc.contributor.author | Kisim, A | |
dc.contributor.author | Uzunoglu, S | |
dc.contributor.author | Uslu, R | |
dc.contributor.author | Karaca, B | |
dc.date.accessioned | 2025-04-10T10:33:19Z | |
dc.date.available | 2025-04-10T10:33:19Z | |
dc.identifier.e-issn | 1527-7755 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | http://hdl.handle.net/20.500.14701/39596 | |
dc.language.iso | English | |
dc.title | Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R) | |
dc.type | Meeting Abstract |